Jurjen Versluis

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Alfons JM van den Eertwegh, Jurjen Versluis, H. Pieter van den Berg et al. · The Lancet Oncology · 2012 · 357 citations

Medicine, Immunology, Oncology +16

Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial

Nadia Alam, Erick Oskam, Patricia M. Stassen et al. · The Lancet Respiratory Medicine · 2017 · 284 citations

Veterinary Medicine, Emergency Medicine, Infectious Diseases +14

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Alexandros Spyridonidis, Myriam Labopin, Bipin N. Savani et al. · Bone Marrow Transplantation · 2020 · 203 citations · Full text

Medicine, Oncology, Stem Cell Transplantation +14

Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation

Jurjen Versluis, Suzan D. Pas, Hendrik J. Agteresch et al. · Blood · 2013 · 132 citations · Full text

Medicine, Hematology, Infectious Diseases +12

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years

Jan J. Cornelissen, Jurjen Versluis, Jakob Passweg et al. · Leukemia · 2014 · 130 citations · Full text

Medicine, Hematology, Oncology +8